4
Changes in Ownership
LIFECORE BIOMEDICAL, INC. \DE\ Filed Acc 0001628280-22-022940
Options or other derivatives
- Chief Financial Officer acquired 26,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Morberg John D Chief Financial Officer | 2022-08-11 | Grant or award · Incentive Stock Option (Right to Buy) | +409 | $11.31 | $4,626 | 409 | D |
| Morberg John D Chief Financial Officer | 2022-08-11 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +12,591 | $11.31 | $142,404 | 13,000 | D |
| Morberg John D Chief Financial Officer | 2022-08-11 | Grant or award · Restricted Stock Unit | +13,500 | $11.31 | $152,685 | 13,500 | D |
Loading xslF345X03/wf-form4_166060256850518.xml…